Skip to main content
Clinical Trials/ITMCTR2200005674
ITMCTR2200005674
Not yet recruiting
Phase 2

Clinical study on the efficacy and safety of Kunbi Xiao Prescription in the treatment of female rheumatoid arthritis

Xi Yuan Hospital of China Academy of Chinese Medical Sciences0 sitesTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Not specified
Sponsor
Xi Yuan Hospital of China Academy of Chinese Medical Sciences
Status
Not yet recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional study
Sex
Female

Investigators

Sponsor
Xi Yuan Hospital of China Academy of Chinese Medical Sciences

Eligibility Criteria

Inclusion Criteria

  • ? Female RA patients who meet the diagnostic criteria of Western medicine and TCM syndrome of Toxic Heat, Phlegm and Blood Stasis Accumulation Syndrome;
  • ?Age 18\-65 years old;
  • ? Disease activity score (DAS28\) \> 3\.2 and \= 5\.1;
  • ? Those who did not participate in any drug trials within 4 weeks before enrollment;
  • ? Voluntary subjects and signed informed consent.

Exclusion Criteria

  • ? Women who are pregnant, breastfeeding, and plan to become pregnant during treatment and/or within 12 weeks after treatment;
  • ? Patients with serious primary diseases or mental illness such as cardiovascular, liver, kidney and hematopoietic system;
  • ? Patients who have been diagnosed with other connective tissue diseases such as systemic lupus erythematosus, Sj?gren's syndrome, myositis or dermatomyositis;
  • ? Patients with pituitary tumor, hyperthyroidism, ovarian cyst and other endocrine diseases, or have a history of uterine and ovarian surgery, or have taken oral contraceptives in recent 4 weeks;
  • ? Those who do not meet the requirements for combined medication;
  • ? Patients who are known to be allergic to any of the traditional Chinese medicines used in this test, or allergic constitution (allergic to two or more drugs, food, pollen);
  • ? Patients with a history of substance abuse, drug or alcohol abuse;
  • ? Other situations that the researcher considers unsuitable to be selected for this project.

Outcomes

Primary Outcomes

Not specified

Similar Trials